Tags: Clinical Safety,Vision
Clinical safety advisory information on National Patient Safety Alert (NPSA) relating to inadvertent oral administration of potassium permanganate.
Opening Tagged Image Format (.TIF) Files from 3rd August 2022 – England Only Due to the way TPP practices send GP2GP data, from the 4rd August 2022 when you select to open an attachment from Vision 3, if it is a .TIF file it automatically opens in Windows Photo Viewer.
When you prescribe high risk drug Sodium Valproate to females, there must be a warning to ensure contraception is provided in view of the significant risks of birth defects and developmental disorders that could occur in children through its use during pregnancy. This applies to females of childbearing age.
Clinical Safety issue where a KIS Special Note recorded for patients registered at Vision GP practices may not be the most recent version of that data
Issue with prescribing generic drugs that are parallel import items using Vision.
Advisory post highlighting the potential for divergence between drug-drug interaction warning severity levels assigned by Cegedim Healthcare Solutions and those included in the BNF and Stockley’s information for interactions.
Tags: Clinical Safety,Vision 3
** RESOLVED ** Vision Consultation Manager crashing on failed bulk reauthorisation of repeat master prescriptions
Tags: Clinical Safety,Vision 3
Advisory post regarding issue relating to age-related prescribing precautions not displaying in Vision when prescribing to neonatal patients under 1 month of age (i.e. 0-28 days old).
When you add a medication, Vision 3 automatically runs specific drug checks depending on your set up. It is important for patient safety that Drug Checks are set up effectively. The Benefits of Automatic Drug Checks guide details the available checks and how to set them up within Vision 3.
Tags: Clinical Safety,Vision
Blog post on National Patient Safety Alert that has been issued on the risk of inappropriate anticoagulation of patients with a mechanical heart valve.